Protocol for high-throughput identification of genes involved in pyroptotic cell death by live microscopy Authors: Aleksandra Bajger, Lukasz S. Borowski, Roman J. Szczesny, Michal P. Wandel Published: 2026 ABSTRACT SummaryIntracellular lipopolysaccharide activates caspase-4/5 triggering pyroptotic cell death. We present a protocol for a high-throughput loss-of-function screening approach to identify interferon-gamma-stimulated genes regulating this pathway. We detail procedures for cell reverse-transfection with a custom-made small interfering RNA (siRNA) library in 384-well plates and priming with interferon-gamma. We then describe steps for transfection with lipopolysaccharide to induce pyroptosis and live-cell fluorescence microscopy using the IncuCyte S3 system to quantify cell death in real time without fixation. This approach enables reliable, high-throughput screening of cell death. Before you begin Ability of individual cells to recognise and respond to threats depend on presence of membrane-bound or cytosolic pattern recognition receptors (PRR). PRRs are responsible for detection of unique microbial molecular structures, known as pathogen-associated molecular patterns (PAMPs), which are evolutionary conserved and crucial for the pathogen survival.1,2 Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-negative bacteria, and a strong immunomodulator. In mammals, LPS recognition depends on two separate pathways. Toll-like 4 receptor in complex with MD2 senses extracellular LPS,3,4 while intracellular LPS is detected by a noncanonical inflammasome.5 Caspase-4/-5 (CASP4/5) in humans and caspase-11 in mice are major components of the noncanonical inflammasome.6,7,8 These caspases can be activated directly via binding hydrophobic lipid A of free LPS to their N-terminal CARD domain,9 or recognize LPS within membranes with positive curvature.10 Activated CASP4/11 processes gasdermin-D (GSDMD) to cause membrane rupture and execute pro-inflammatory cell death – pyroptosis, which is critical for endotoxic shock in mice, and to protect against cytosol invading bacteria.11,12,13 To promote the noncanonical inflammasome activity in non-immune human cells, the presence of interferon-gamma (IFN-γ) is required,14,15 however, the exact role of IFN-γ stimulated genes (ISGs) in the formation and activation of noncanonical inflammasome is not fully understood. This protocol describes a robust, high-throughput method for systematic identification of ISGs involved in noncanonical inflammasome-mediated pyroptosis. Our approach combines siRNA loss-of-function screening with real-time live fluorescence microscopy using the IncuCyte S3 system to monitor pyroptotic cell death triggered by intracellular LPS. First, epithelial HeLa cells are transfected with siRNA library prepared in 384-well format and designed against ISGs selected by evaluating the transcriptional response of cells and tissues stimulated with IFN-γ,16,17 further referred as the siRNA library (Data S1). Following 36 h of knockdown, cells are primed with IFN-γ to stimulate expression of ISGs. Next, after 12 h of priming cells are transfected with LPS from Salmonella enterica serovar Typhimurium to induce cell death. Cells are visualized with fluorescence microscopy using the IncuCyte S3 system for direct real-time imaging of live, unfixed cells. Later, results are calculated as a ratio of dead cells to all cells in the population. If particular gene is involved in the pyroptosis, its silencing causes decreased levels of cell death compared to negative controls. The protocol below describes the specific steps for using HeLa cells. However, we have also applied this protocol for high-throughput siRNA transfection in human melanoma MJS (also known as MelJuSo) and 293 cells.18,19 Hence, cell lines different from HeLa, or primary cells, provided they can be transfected efficiently with siRNA and respond to IFN-γ, as well as various siRNA libraries can be used with this protocol. With small modifications, this protocol can be used in screening where cells are challenged with different inhibitors, inflammatory agonists and/or infected with intracellular pathogens. Innovation Pyroptosis is a critical inflammatory cell death pathway with important roles in host defense, autoinflammatory diseases, and cancer.5,20 Understanding the molecular mechanisms regulating pyroptosis has significant implications for developing therapeutic interventions. Our protocol provides researchers with a practical, reproducible method for systematic identification of genes controlling this important cellular process. High-throughput assays carried out in a 384-well plate format enable to collect large amount of data in a single experiment while maintaining statistical power and experimental efficiency. However, if the performed assay involves samples visualization with fluorescence microscopy, this can take significant amount of time, and thus requires samples fixation. In many immune processes threat detection leads to the death of a challenged cell, and fixation of such sample can lead to artifacts and false-positive results. In this protocol, IncuCyte S3 system is used for fluorescence microscopy and direct cell death detection without cell fixation. This machine allows interference-free continuous monitoring of cells directly in the incubator environment with integrated image analysis enabling more accurate and physiologically relevant data collection. In addition, our protocol has been optimized to avoid media replacement steps; not only to simplify the screening procedure but also to improve data quality in high-throughput formats by limiting unnecessary disturbance, stress or cell loss. Advancements that we implemented in our high-throughput analysis open a new opportunity for studies of immune pathways, as well as all processes where sample fixation in experimental design may disturb obtained results. siRNA library design Timing: 1–2 months before experiment 1.Select genes that are to be targeted by siRNAs.2.Design on your own or select pre-designed siRNAs to build an siRNA library targeting a group of genes of your choice. Note: siRNA library used in this study was purchased from ThermoFischer Scientific. We use Silencer Select System. Library consists of two siRNAs against each tested gene. Note: While ordering siRNA library, make sure that your library will be placed in columns 5–20 and rows 2–23 of 384-well plates. Note: Keep some empty rows and columns for future addition of screening controls. CRITICAL: Avoid using wells located at the very edge of a plate as they may evaporate quicker than the rest of the plate, depending on your screening timeline and applied culturing conditions. Note: Before resuspension store siRNA library at −20°C. Timing: 1–2 months before experiment 1.Select genes that are to be targeted by siRNAs. Select genes that are to be targeted by siRNAs. 2.Design on your own or select pre-designed siRNAs to build an siRNA library targeting a group of genes of your choice. Design on your own or select pre-designed siRNAs to build an siRNA library targeting a group of genes of your choice. Note: siRNA library used in this study was purchased from ThermoFischer Scientific. We use Silencer Select System. Library consists of two siRNAs against each tested gene. Note: While ordering siRNA library, make sure that your library will be placed in columns 5–20 and rows 2–23 of 384-well plates. Note: Keep some empty rows and columns for future addition of screening controls. CRITICAL: Avoid using wells located at the very edge of a plate as they may evaporate quicker than the rest of the plate, depending on your screening timeline and applied culturing conditions. Note: Before resuspension store siRNA library at −20°C. Media preparation Timing: 40 min 3.Prepare the following media:a.Complete IMDM medium (see materials and equipment section).b.To make Opti-MEM medium add 300 μL of gentamycin (or antibiotic routinely used in the cell culture in the laboratory) to 500 mL of Opti-MEM medium. Final concentration of gentamycin is 30 μg/mL. Note: Store in 4°C up to 3 months. Note: All procedures described in the following protocol are performed under sterile working conditions. All operations with cells are carried out in a laminar flow chamber, while wearing personal protective equipment. Timing: 40 min 3.Prepare the following media:a.Complete IMDM medium (see materials and equipment section).b.To make Opti-MEM medium add 300 μL of gentamycin (or antibiotic routinely used in the cell culture in the laboratory) to 500 mL of Opti-MEM medium. Final concentration of gentamycin is 30 μg/mL. Prepare the following media:a.Complete IMDM medium (see materials and equipment section).b.To make Opti-MEM medium add 300 μL of gentamycin (or antibiotic routinely used in the cell culture in the laboratory) to 500 mL of Opti-MEM medium. Final concentration of gentamycin is 30 μg/mL. a.Complete IMDM medium (see materials and equipment section). Complete IMDM medium (see materials and equipment section). b.To make Opti-MEM medium add 300 μL of gentamycin (or antibiotic routinely used in the cell culture in the laboratory) to 500 mL of Opti-MEM medium. Final concentration of gentamycin is 30 μg/mL. To make Opti-MEM medium add 300 μL of gentamycin (or antibiotic routinely used in the cell culture in the laboratory) to 500 mL of Opti-MEM medium. Final concentration of gentamycin is 30 μg/mL. Note: Store in 4°C up to 3 months. Note: All procedures described in the following protocol are performed under sterile working conditions. All operations with cells are carried out in a laminar flow chamber, while wearing personal protective equipment. SiRNA library preparation Timing: 2 h Timing: 2 h This step aims to resuspend dried-down siRNA in 384-well plates. Parental library plates used in this screening consist of 0.1 nmole of each siRNA. Dissolve parental plate to concentration of 2.5 μM, and then prepare intermediate dilution of 440 nM. Intermediate dilutions are later used to prepare assay plates.4.Allow for siRNA to warm up slowly to 22°C.5.Resuspend siRNA in parental plates in ultrapure water. Add 40 μL of water per well to entire plate.CRITICAL: We strongly recommend using a commercially available RNase-free water.Optional: To facilitate work, use automated liquid handling workstation, such as JANUS from Perkin Elmer.6.Incubate the plate for 30 min at 22°C to allow siRNA to dissolve.7.Prepare intermediate siRNA dilutions.a.Add 59 μL of RNase-free water to each well of 384-well plate (Storage Plate, Abgene).b.Mix dissolved stock of siRNA (point 5) and transfer 13 μL of siRNA per well from parental plate to a new 384-well plate with dispensed 59 μL of water (point 7a).8.Seal the plates with Heat Sealing Foil (Easy Peel Heat Sealing Foil).Note: Store siRNA library at −80°C. 4.Allow for siRNA to warm up slowly to 22°C. Allow for siRNA to warm up slowly to 22°C. 5.Resuspend siRNA in parental plates in ultrapure water. Add 40 μL of water per well to entire plate. Resuspend siRNA in parental plates in ultrapure water. Add 40 μL of water per well to entire plate. CRITICAL: We strongly recommend using a commercially available RNase-free water. Optional: To facilitate work, use automated liquid handling workstation, such as JANUS from Perkin Elmer. 6.Incubate the plate for 30 min at 22°C to allow siRNA to dissolve. Incubate the plate for 30 min at 22°C to allow siRNA to dissolve. 7.Prepare intermediate siRNA dilutions.a.Add 59 μL of RNase-free water to each well of 384-well plate (Storage Plate, Abgene).b.Mix dissolved stock of siRNA (point 5) and transfer 13 μL of siRNA per well from parental plate to a new 384-well plate with dispensed 59 μL of water (point 7a). Prepare intermediate siRNA dilutions.a.Add 59 μL of RNase-free water to each well of 384-well plate (Storage Plate, Abgene).b.Mix dissolved stock of siRNA (point 5) and transfer 13 μL of siRNA per well from parental plate to a new 384-well plate with dispensed 59 μL of water (point 7a). a.Add 59 μL of RNase-free water to each well of 384-well plate (Storage Plate, Abgene). Add 59 μL of RNase-free water to each well of 384-well plate (Storage Plate, Abgene). b.Mix dissolved stock of siRNA (point 5) and transfer 13 μL of siRNA per well from parental plate to a new 384-well plate with dispensed 59 μL of water (point 7a). Mix dissolved stock of siRNA (point 5) and transfer 13 μL of siRNA per well from parental plate to a new 384-well plate with dispensed 59 μL of water (point 7a). 8.Seal the plates with Heat Sealing Foil (Easy Peel Heat Sealing Foil). Seal the plates with Heat Sealing Foil (Easy Peel Heat Sealing Foil). Note: Store siRNA library at −80°C. Subculturing cells for transfection Timing: 20 min Note: Subculture cells a day before siRNA transfection. 9.Seed 2.5 × 106 HeLa cells on a 100 mm dishes (2–3 plates) so they will reach a confluency of approximately 90% on the next day (5 × 106 of HeLa cells). Timing: 20 min Note: Subculture cells a day before siRNA transfection. 9.Seed 2.5 × 106 HeLa cells on a 100 mm dishes (2–3 plates) so they will reach a confluency of approximately 90% on the next day (5 × 106 of HeLa cells). Seed 2.5 × 106 HeLa cells on a 100 mm dishes (2–3 plates) so they will reach a confluency of approximately 90% on the next day (5 × 106 of HeLa cells). Key resources table REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesMonoclonal anti-caspase-4 (Human) antibody produced in mouse (diluted 1:1000)MBLCat.# M029-3Clone: 4B9Monoclonal anti-β-actin antibody produced in rabbit (diluted 1:10 000)AbcloncalCat.# AC038-100Clone: ARC5115-01Chemicals, peptides, and recombinant proteinsIscove’s Modified Dulbecco’s Medium (IMDM) w/Stable Glutamine w/25 mM HepesBioWestCat.# L0191Gibco Opti-MEM Reduced Serum MediumThermo Fischer ScientificCat.#31985070Fetal Bovine Serum (FBS)EURxCat.#E5050-02Gentamycin Sulfate 50 mg/mLBiowestCat.# L0012RN-ase free, molecular grade waterDharmaconCat.#B-003000-WB-100Phosphate-Buffered Saline (PBS)VWRCat.#392–0434Trypsin 0.25% - EDTA IN HBSS W/O CA-MGBiowestCat.# L0931-500Lipofectamine RNAiMAX Transfection ReagentThermo Fischer ScientificCat.#13778150Lipofectamine 2000 Transfection ReagentThermo Fischer ScientificCat.#11668019MilliQ waterN/AN/AEthanol, 96% reinst, Ph.Eur.ChemsoluteCat.#2286.1000Recombinant Human Interferon-γR&DCat.#285-IFLipopolysaccharides from Salmonella enterica serotype typhimuriumSigma-AldrichCat.#L6511-10MGSYTO 9 Green Fluorescent Nucleic Acid StainsThermo Fischer ScientificCat.# S34854Propidium iodideSigma-AldrichCat.#81845-25MGExperimental models: Cell linesHuman HeLa cellsATCCCat.#CCL-2OligonucleotidesCustom-made Silencer Select siRNA libraryThermo Fischer Scientific/this studyN/ASilencer Select Negative Control No. 1 siRNA (siCONTROL)Thermo Fischer ScientificCat.#4390843SiCASPASE-4 (CASP4)Thermo Fischer ScientificCat.#s2414OtherIncucyte S3Sartoriushttps://www.sartorius.com/en/products/live-cell-imaging-analysis/live-cell-analysis-instruments/s3-live-cell-analysis-instrumentCell culture microplate, 384 well, ps, black, poly-d-lysineGreinerCat.#781946Cell culture microplate, 384 well, ps, f-bottom, clearGreinerCat.#781182Cell culture microplate, 96 well, ps, f-bottom, clearGreinerCat.#655180ABgene Storage Plate, 384- well, square wellAbgeneCat.#AB0781BioLite 100 mm Dish Cell Culture-treated SurfaceThermo Fischer ScietificCat.#130182Easy Peel Heat Sealing FoilThermo Fischer ScietificCat.#AB-0745Adhesive sealing film (foil)NerbeCat.#04–095–006050 ml falcon tubesThermo Fischer ScietificCat.#33965215 ml falcon tubesThermo Fischer ScietificCat.#339650Costar 250 mL Traditional Style Polystyrene Storage Bottles with 45 mm Caps (for preparation of cells mixture)CorningCat.#8390Falcon 5 mL Round Bottom Polystyrene Test Tube, with Cell Strainer Snap CapCorningCat.#3522351.5 ml eppendorf tubesBiologixCat.#80–1500Laser Cryo-Tags sidewallSigma-AldrichCat.# Z743433-3120EAThoma counting chamberVWRCat.#HECH40440701Multidrop Combi Reagent DispenserThermo Fischer ScietificCat.#5840330Small tube metal tip dispensing cassette (Multidrop Combi Accessory)Thermo Fischer ScietificCat.#24073295Magnetic stirrerGilsonCat.#01.262627PTFE Pivot Ring Stirrer BarVWRCat.#442–4510JANUS® MDTPerkin Elmer/Revvityhttps://www.revvity.com/category/janus-workstationsCentrifuge 5430EppendorfCat.#5427000015 REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesMonoclonal anti-caspase-4 (Human) antibody produced in mouse (diluted 1:1000)MBLCat.# M029-3Clone: 4B9Monoclonal anti-β-actin antibody produced in rabbit (diluted 1:10 000)AbcloncalCat.# AC038-100Clone: ARC5115-01Chemicals, peptides, and recombinant proteinsIscove’s Modified Dulbecco’s Medium (IMDM) w/Stable Glutamine w/25 mM HepesBioWestCat.# L0191Gibco Opti-MEM Reduced Serum MediumThermo Fischer ScientificCat.#31985070Fetal Bovine Serum (FBS)EURxCat.#E5050-02Gentamycin Sulfate 50 mg/mLBiowestCat.# L0012RN-ase free, molecular grade waterDharmaconCat.#B-003000-WB-100Phosphate-Buffered Saline (PBS)VWRCat.#392–0434Trypsin 0.25% - EDTA IN HBSS W/O CA-MGBiowestCat.# L0931-500Lipofectamine RNAiMAX Transfection ReagentThermo Fischer ScientificCat.#13778150Lipofectamine 2000 Transfection ReagentThermo Fischer ScientificCat.#11668019MilliQ waterN/AN/AEthanol, 96% reinst, Ph.Eur.ChemsoluteCat.#2286.1000Recombinant Human Interferon-γR&DCat.#285-IFLipopolysaccharides from Salmonella enterica serotype typhimuriumSigma-AldrichCat.#L6511-10MGSYTO 9 Green Fluorescent Nucleic Acid StainsThermo Fischer ScientificCat.# S34854Propidium iodideSigma-AldrichCat.#81845-25MGExperimental models: Cell linesHuman HeLa cellsATCCCat.#CCL-2OligonucleotidesCustom-made Silencer Select siRNA libraryThermo Fischer Scientific/this studyN/ASilencer Select Negative Control No. 1 siRNA (siCONTROL)Thermo Fischer ScientificCat.#4390843SiCASPASE-4 (CASP4)Thermo Fischer ScientificCat.#s2414OtherIncucyte S3Sartoriushttps://www.sartorius.com/en/products/live-cell-imaging-analysis/live-cell-analysis-instruments/s3-live-cell-analysis-instrumentCell culture microplate, 384 well, ps, black, poly-d-lysineGreinerCat.#781946Cell culture microplate, 384 well, ps, f-bottom, clearGreinerCat.#781182Cell culture microplate, 96 well, ps, f-bottom, clearGreinerCat.#655180ABgene Storage Plate, 384- well, square wellAbgeneCat.#AB0781BioLite 100 mm Dish Cell Culture-treated SurfaceThermo Fischer ScietificCat.#130182Easy Peel Heat Sealing FoilThermo Fischer ScietificCat.#AB-0745Adhesive sealing film (foil)NerbeCat.#04–095–006050 ml falcon tubesThermo Fischer ScietificCat.#33965215 ml falcon tubesThermo Fischer ScietificCat.#339650Costar 250 mL Traditional Style Polystyrene Storage Bottles with 45 mm Caps (for preparation of cells mixture)CorningCat.#8390Falcon 5 mL Round Bottom Polystyrene Test Tube, with Cell Strainer Snap CapCorningCat.#3522351.5 ml eppendorf tubesBiologixCat.#80–1500Laser Cryo-Tags sidewallSigma-AldrichCat.# Z743433-3120EAThoma counting chamberVWRCat.#HECH40440701Multidrop Combi Reagent DispenserThermo Fischer ScietificCat.#5840330Small tube metal tip dispensing cassette (Multidrop Combi Accessory)Thermo Fischer ScietificCat.#24073295Magnetic stirrerGilsonCat.#01.262627PTFE Pivot Ring Stirrer BarVWRCat.#442–4510JANUS® MDTPerkin Elmer/Revvityhttps://www.revvity.com/category/janus-workstationsCentrifuge 5430EppendorfCat.#5427000015 Materials and equipment Complete IMDM mediumCompoundAmountFinal concentrationIMDM449.70 mLN/AFetal bovine serum (FBS)50 mL10 %Gentamycin300 μL30 μg/mLTotal500 mLN/A Complete IMDM mediumCompoundAmountFinal concentrationIMDM449.70 mLN/AFetal bovine serum (FBS)50 mL10 %Gentamycin300 μL30 μg/mLTotal500 mLN/A Note: Store complete IMDM medium at 4°C up to 3 months. Note: Prior to addition to the medium, FBS is thawed at 37°C and then heat-inactivated at 55°C for 30 min. Alternatives: DMEM medium can be used as well. Alternatives: You can replace gentamycin with the penicillin/streptomycin mixture. Antibiotics selection should not affect experiment. Choose antibiotics that are routinely used in the cell culture in the laboratory. LPS transfection mixtureSolution ISolution IIReagentVolumeReagentVolumeOpti-MEM2.25 mLOpti-MEM2.25 mLLPS225 μLLipofectamine 200045 μLTotal volume: 4.77 mL Note: Store complete IMDM medium at 4°C up to 3 months. Note: Prior to addition to the medium, FBS is thawed at 37°C and then heat-inactivated at 55°C for 30 min. Alternatives: DMEM medium can be used as well. Alternatives: You can replace gentamycin with the penicillin/streptomycin mixture. Antibiotics selection should not affect experiment. Choose antibiotics that are routinely used in the cell culture in the laboratory. LPS transfection mixtureSolution ISolution IIReagentVolumeReagentVolumeOpti-MEM2.25 mLOpti-MEM2.25 mLLPS225 μLLipofectamine 200045 μLTotal volume: 4.77 mL Note: Always prepare freshly in 15 mL tubes, mix Solution I thoroughly and Solution II carefully before combining and mixing them together carefully. Note: Our LPS stock solution is 1 mg/mL. The final concentration of the LPS in the experiment is 6.21 μg/mL. Fluorescent dyes solutionReagentFinal concentrationAmountComplete IMDM mediumN/A21.956 mLSYTO 9 Green (5 mM)0.66 μM22 μLPI (2.5 mg/mL)0.33 μg/mL22 μLTotalN/A22 mL Note: Always prepare freshly in 15 mL tubes, mix Solution I thoroughly and Solution II carefully before combining and mixing them together carefully. Note: Our LPS stock solution is 1 mg/mL. The final concentration of the LPS in the experiment is 6.21 μg/mL. Fluorescent dyes solutionReagentFinal concentrationAmountComplete IMDM mediumN/A21.956 mLSYTO 9 Green (5 mM)0.66 μM22 μLPI (2.5 mg/mL)0.33 μg/mL22 μLTotalN/A22 mL Note: Mix thoroughly in 50 mL tube. Note: Mix thoroughly in 50 mL tube. Step-by-step method details Preparation of siRNA assay plates Timing: 1 day Timing: 1 day This step aims to prepare assay plates with siRNAs for a screening experiment. For this, use intermediate plates from siRNA library (concentration - 440 nM). Dilute siRNAs in Opti-MEM medium to obtain siRNA in final concentration of 110 nM.Optional: To facilitate work, use automated liquid handling workstation, such as JANUS ® from Perkin Elmer.1.Thaw intermediate plates from siRNA library at 22°C.2.Prepare siRNA dilution in Opti-MEM medium.Note: The steps shown below apply while preparing assay plates for three replicates.a.Add 18 μL of Opti-MEM medium to each well of a 384-well plate (f-bottom, clear, Greiner).Note: This is not an assay plate.b.Add 6 μL of siRNA from the intermediate plates to the Opti-MEM dispensed in step 2a.c.Mix slowly twice.3.Prepare solutions of siRNA serving as negative and positive controls in the screening (Figure 1A). Their final concentration will be 440 nM.a.Take a 96-well plate. Transfer 166.8 μL of Opti-MEM medium to seven wells of one column of the plate.b.Add 13.2 μL of 6 μM siControl to Opti-MEM medium in rows A-E (five wells).c.Add 13.2 μL of 6 μM siCaspase-4 (siCASP4) solution to Opti-MEM medium in rows F-G (two wells).Note: Use siControl as a negative control in the experiment and siCASP4 as a positive control. In the absence of caspase-4 pyroptosis is blocked.d.With multichannel pipette transfer 6 μL of each siRNA control solutions (prepared in step 3b,c) to siRNA-containing 384-well plates (prepared in step 2).i.Add siControl to rows B-K of columns 4 and 21 (Figure 1A).ii.Add siCASP4 to rows L-O of columns 4 and 21 (Figure 1A).Figure 1Assay plate layout for siRNA screening(A) Schematic siRNA distribution pattern on the assay plate.(B) Schematic representation of IFN-γ addition to the assay plate.4.Prepare assay plates for screening.CRITICAL: Use 384-well plates with black walls and transparent, fluorescent microscopy compatible bottom. Fully transparent or even opaque plates may cause the interruptions of the fluorescence signal between the wells.a.Label assay plates. Use stickers.b.Transfer 5 μL of siRNA solution (prepared in step 2 and 3, with concentration of 110 nM) to each well of the empty black 384-well plate.Note: To minimize the risk of drying out leave the outermost wells of the plate without tested siRNAs.Note: Use columns 3 and 22 as growth control columns (without siRNA transfection) (Figure 1A). We use these columns to evaluate fitness of untreated cells throughout the experiment.5.Seal the plate with the easily removable foil and store them at 4°C.Pause point: Store prepared siRNA assay plates at 4°C. Use them in a high-throughput experiment within 14 days. Optional: To facilitate work, use automated liquid handling workstation, such as JANUS ® from Perkin Elmer. 1.Thaw intermediate plates from siRNA library at 22°C. Thaw intermediate plates from siRNA library at 22°C. 2.Prepare siRNA dilution in Opti-MEM medium.Note: The steps shown below apply while preparing assay plates for three replicates.a.Add 18 μL of Opti-MEM medium to each well of a 384-well plate (f-bottom, clear, Greiner).Note: This is not an assay plate.b.Add 6 μL of siRNA from the intermediate plates to the Opti-MEM dispensed in step 2a.c.Mix slowly twice. Prepare siRNA dilution in Opti-MEM medium.Note: The steps shown below apply while preparing assay plates for three replicates.a.Add 18 μL of Opti-MEM medium to each well of a 384-well plate (f-bottom, clear, Greiner).Note: This is not an assay plate.b.Add 6 μL of siRNA from the intermediate plates to the Opti-MEM dispensed in step 2a.c.Mix slowly twice. Note: The steps shown below apply while preparing assay plates for three replicates. a.Add 18 μL of Opti-MEM medium to each well of a 384-well plate (f-bottom, clear, Greiner).Note: This is not an assay plate. Add 18 μL of Opti-MEM medium to each well of a 384-well plate (f-bottom, clear, Greiner).Note: This is not an assay plate. Note: This is not an assay plate. b.Add 6 μL of siRNA from the intermediate plates to the Opti-MEM dispensed in step 2a. Add 6 μL of siRNA from the intermediate plates to the Opti-MEM dispensed in step 2a. c.Mix slowly twice. Mix slowly twice. 3.Prepare solutions of siRNA serving as negative and positive controls in the screening (Figure 1A). Their final concentration will be 440 nM.a.Take a 96-well plate. Transfer 166.8 μL of Opti-MEM medium to seven wells of one column of the plate.b.Add 13.2 μL of 6 μM siControl to Opti-MEM medium in rows A-E (five wells).c.Add 13.2 μL of 6 μM siCaspase-4 (siCASP4) solution to Opti-MEM medium in rows F-G (two wells).Note: Use siControl as a negative control in the experiment and siCASP4 as a positive control. In the absence of caspase-4 pyroptosis is blocked.d.With multichannel pipette transfer 6 μL of each siRNA control solutions (prepared in step 3b,c) to siRNA-containing 384-well plates (prepared in step 2).i.Add siControl to rows B-K of columns 4 and 21 (Figure 1A).ii.Add siCASP4 to rows L-O of columns 4 and 21 (Figure 1A).Figure 1Assay plate layout for siRNA screening(A) Schematic siRNA distribution pattern on the assay plate.(B) Schematic representation of IFN-γ addition to the assay plate. Prepare solutions of siRNA serving as negative and positive controls in the screening (Figure 1A). Their final concentration will be 440 nM.a.Take a 96-well plate. Transfer 166.8 μL of Opti-MEM medium to seven wells of one column of the plate.b.Add 13.2 μL of 6 μM siControl to Opti-MEM medium in rows A-E (five wells).c.Add 13.2 μL of 6 μM siCaspase-4 (siCASP4) solution to Opti-MEM medium in rows F-G (two wells).Note: Use siControl as a negative control in the experiment and siCASP4 as a positive control. In the absence of caspase-4 pyroptosis is blocked.d.With multichannel pipette transfer 6 μL of each siRNA control solutions (prepared in step 3b,c) to siRNA-containing 384-well plates (prepared in step 2).i.Add siControl to rows B-K of columns 4 and 21 (Figure 1A).ii.Add siCASP4 to rows L-O of columns 4 and 21 (Figure 1A).Figure 1Assay plate layout for siRNA screening(A) Schematic siRNA distribution pattern on the assay plate.(B) Schematic representation of IFN-γ addition to the assay plate. a.Take a 96-well plate. Transfer 166.8 μL of Opti-MEM medium to seven wells of one column of the plate. Take a 96-well plate. Transfer 166.8 μL of Opti-MEM medium to seven wells of one column of the plate. b.Add 13.2 μL of 6 μM siControl to Opti-MEM medium in rows A-E (five wells). Add 13.2 μL of 6 μM siControl to Opti-MEM medium in rows A-E (five wells). c.Add 13.2 μL of 6 μM siCaspase-4 (siCASP4) solution to Opti-MEM medium in rows F-G (two wells).Note: Use siControl as a negative control in the experiment and siCASP4 as a positive control. In the absence of caspase-4 pyroptosis is blocked. Add 13.2 μL of 6 μM siCaspase-4 (siCASP4) solution to Opti-MEM medium in rows F-G (two wells).Note: Use siControl as a negative control in the experiment and siCASP4 as a positive control. In the absence of caspase-4 pyroptosis is blocked. Note: Use siControl as a negative control in the experiment and siCASP4 as a positive control. In the absence of caspase-4 pyroptosis is blocked. d.With multichannel pipette transfer 6 μL of each siRNA control solutions (prepared in step 3b,c) to siRNA-containing 384-well plates (prepared in step 2).i.Add siControl to rows B-K of columns 4 and 21 (Figure 1A).ii.Add siCASP4 to rows L-O of columns 4 and 21 (Figure 1A). With multichannel pipette transfer 6 μL of each siRNA control solutions (prepared in step 3b,c) to siRNA-containing 384-well plates (prepared in step 2).i.Add siControl to rows B-K of columns 4 and 21 (Figure 1A).ii.Add siCASP4 to rows L-O of columns 4 and 21 (Figure 1A). i.Add siControl to rows B-K of columns 4 and 21 (Figure 1A). Add siControl to rows B-K of columns 4 and 21 (Figure 1A). ii.Add siCASP4 to rows L-O of columns 4 and 21 (Figure 1A). Add siCASP4 to rows L-O of columns 4 and 21 (Figure 1A). Assay plate layout for siRNA screening (A) Schematic siRNA distribution pattern on the assay plate. (B) Schematic representation of IFN-γ addition to the assay plate. 4.Prepare assay plates for screening.CRITICAL: Use 384-well plates with black walls and transparent, fluorescent microscopy compatible bottom. Fully transparent or even opaque plates may cause the interruptions of the fluorescence signal between the wells.a.Label assay plates. Use stickers.b.Transfer 5 μL of siRNA solution (prepared in step 2 and 3, with concentration of 110 nM) to each well of the empty black 384-well plate.Note: To minimize the risk of drying out leave the outermost wells of the plate without tested siRNAs.Note: Use columns 3 and 22 as growth control columns (without siRNA transfection) (Figure 1A). We use these columns to evaluate fitness of untreated cells throughout the experiment. Prepare assay plates for screening.CRITICAL: Use 384-well plates with black walls and transparent, fluorescent microscopy compatible bottom. Fully transparent or even opaque plates may cause the interruptions of the fluorescence signal between the wells.a.Label assay plates. Use stickers.b.Transfer 5 μL of siRNA solution (prepared in step 2 and 3, with concentration of 110 nM) to each well of the empty black 384-well plate.Note: To minimize the risk of drying out leave the outermost wells of the plate without tested siRNAs.Note: Use columns 3 and 22 as growth control columns (without siRNA transfection) (Figure 1A). We use these columns to evaluate fitness of untreated cells throughout the experiment. CRITICAL: Use 384-well plates with black walls and transparent, fluorescent microscopy compatible bottom. Fully transparent or even opaque plates may cause the interruptions of the fluorescence signal between the wells. a.Label assay plates. Use stickers. Label assay plates. Use stickers. b.Transfer 5 μL of siRNA solution (prepared in step 2 and 3, with concentration of 110 nM) to each well of the empty black 384-well plate.Note: To minimize the risk of drying out leave the outermost wells of the plate without tested siRNAs.Note: Use columns 3 and 22 as growth control columns (without siRNA transfection) (Figure 1A). We use these columns to evaluate fitness of untreated cells throughout the experiment. Transfer 5 μL of siRNA solution (prepared in step 2 and 3, with concentration of 110 nM) to each well of the empty black 384-well plate.Note: To minimize the risk of drying out leave the outermost wells of the plate without tested siRNAs.Note: Use columns 3 and 22 as growth control columns (without siRNA transfection) (Figure 1A). We use these columns to evaluate fitness of untreated cells throughout the experiment. Note: To minimize the risk of drying out leave the outermost wells of the plate without tested siRNAs. Note: Use columns 3 and 22 as growth control columns (without siRNA transfection) (Figure 1A). We use these columns to evaluate fitness of untreated cells throughout the experiment. 5.Seal the plate with the easily removable foil and store them at 4°C. Seal the plate with the easily removable foil and store them at 4°C. Pause point: Store prepared siRNA assay plates at 4°C. Use them in a high-throughput experiment within 14 days. High-throughput reverse siRNA transfection of HeLa cells Timing: 5 h Timing: 5 h In this step, seed HeLa cells in assay plates containing siRNA. Prior to cells seeding, mix siRNA with transfection reagent (RNAiMAX) which enables the siRNA to enter the cell.Note: We use IncuCyte S3 device for cells visualization. This machine contains 6 slots for plates, thus do not transfect more than six plates at a time.Alternatives: Several alternative systems could perform in-incubator fluorescent live-cell imaging, e.g., Invitrogen EVOS M7000 Imaging System, Axion Biosystems Omni Pro 12, ECHO Cellcyte 1, or Perkin Elmer Operetta High-Content Imaging System.Optional: To facilitate work in 384-well plate format, we suggest to pipette transfection reagent and seed cells with Multidrop Combi Reagent Dispenser (ThermoFisher Scientific).6.Centrifuge assay plates containing siRNAs – 300 × g/30 s.7.Place assay plates in the laminar flow chamber, peel off the foil. Cover plates with lids.8.Prepare magnetic stirrer and magnetic stirrer bar.a.Filter MilliQ water (120 mL) under the laminar flow chamber.b.Transfer 50 mL of MilliQ water to two sterile vessels with flat bottom. Transfer 20 mL of MilliQ water to the third vessel.c.Fill another 1 flat bottom vessel with 20 mL of 70% ethanol.d.Place magnetic stirrer bar in an ethanol-containing vessel and put it for 5 min on a magnetic stirrer.e.Transfer magnetic stirrer bar to vessel filled with 50 mL of MilliQ water (step 8b), and put it back on a magnetic stirrer. Repeat this twice.f.Transfer magnetic stirrer bar to the vessel with 20 mL of MilliQ water (step 8b). It is ready to use.9.Prepare Multidrop for work.a.Rinse the device cassette with 5 mL of MilliQ water.b.Rinse the cassette with 5 mL of 70% ethanol.c.Rinse it one more time with 5 mL of MilliQ water.10.Fill the columns 1–3 and 22–24 with 20 μL of Opti-MEM medium.CRITICAL: Before dispensing reagents with Multidrop perform priming to make sure its cassette is filled with them.11.Prepare transfection mixture. To transfect six 384-well plates (columns 4–21), prepare 12.12 mL of it.a.Add 12 mL of Opti-MEM medium to 50 mL tube.b.Add 120 μL of RNAiMAX transfection reagent.c.Mix slowly few times.12.Add 5 μL of the transfection mixture to columns 4–21 of assay plates (already containing 5 μL of siRNA; step 4b).CRITICAL: After adding transfection agent to assay plates, seed cells within 40 min. Do not allow RNAiMAX for longer incubation with siRNA only, as it may affect transfection efficiency.13.Trypsinize HeLa cells from 10 cm dish prepared a day before transfection (follow standard lab procedure).a.Pre-warm sterile PBS, trypsin-EDTA and complete IMDM medium at 37°C in a water bath.b.Aspirate the culture medium from the plate.c.Wash the cells monolayer with 5 ml of sterile PBS.d.Add pre-warmed trypsin-EDTA solution in PBS (0.5 ml of trypsin-EDTA in 1.5 ml of PBS) to cells.e.Incubate at 37°C for 5 to 10 min.f.Add 3 ml of complete IMDM medium to the plate.14.Take 1/5 of detached cells (1 mL) and seed them in fresh 10 cm dish (cells growth control).15.Take another 1/5 of detached cells (1 mL), and pipette them through a 5 mL tube with a strainer in a cap to remove cell aggregates.16.Transfer 500 μL of cells suspension to 1.5 mL tube and count cells 4 times e.g., in a Thoma chamber.Note: Consider if cells dilution is needed for accurate counting.17.Prepare 100 mL of cell mixture of final concentration 2 × 104 cells/mL.18.Place the cell mixture on a magnetic stirrer, carefully put a magnetic stirrer bar in the cell mixture. Set a gentle mixing.19.Dispense 40 μL of cells mixture to siRNA/transfection mixture containing columns 4–21 of 384-well assay plates with Multidrop. It results in putting 800 cell/well for transfected wells.20.Dispense 25 μL of cells mixture to columns 1–3 and 22–24. It results in putting 500 cell/well for non-transfected wells.Note: Final siRNA concentration in the screening is 11 nM.Note: The number of cells used for transfection must be established experimentally. It depends on cells doubling-time, selected time of culture after transfection and sensitivity of cells to the transfection procedure.Note: To limit media evaporation from experimental wells and to avoid an extra step of adding media alone, we fill columns 1–2 and 23–24 with a cell mixture. These columns are not stained later and are excluded from data collection.Optional: For cells sensitive to transfection, account for transfection-induced cell death and calculate pyroptosis-specific cell death by using parts of columns 1–3 and 22–24 (e.g., columns 3 and 22) to evaluate baseline cell death. Dispense 40 μL of the cell mixture into a mock transfection mixture (prepared per step 11, without siRNA) in the designated columns of 384-well assay plates using a Multidrop dispenser. This dispenses 800 cells/well for transfected wells. If you use columns 3 and 22 for background cell death, shift the position of the growth control columns (e.g., to columns 2 and 23).21.Incubate plates for 1 h at 22°C under the laminar flow chamber.22.Transfer plates to cell culture incubator (37°C, 5% CO2) keep them individually for 1 h and then stack them.23.Incubate plates in the incubator for 36 h. Note: We use IncuCyte S3 device for cells visualization. This machine contains 6 slots for plates, thus do not transfect more than six plates at a time. Alternatives: Several alternative systems could perform in-incubator fluorescent live-cell imaging, e.g., Invitrogen EVOS M7000 Imaging System, Axion Biosystems Omni Pro 12, ECHO Cellcyte 1, or Perkin Elmer Operetta High-Content Imaging System. Optional: To facilitate work in 384-well plate format, we suggest to pipette transfection reagent and seed cells with Multidrop Combi Reagent Dispenser (ThermoFisher Scientific). 6.Centrifuge assay plates containing siRNAs – 300 × g/30 s. Centrifuge assay plates containing siRNAs – 300 × g/30 s. 7.Place assay plates in the laminar flow chamber, peel off the foil. Cover plates with lids. Place assay plates in the laminar flow chamber, peel off the foil. Cover plates with lids. 8.Prepare magnetic stirrer and magnetic stirrer bar.a.Filter MilliQ water (120 mL) under the laminar flow chamber.b.Transfer 50 mL of MilliQ water to two sterile vessels with flat bottom. Transfer 20 mL of MilliQ water to the third vessel.c.Fill another 1 flat bottom vessel with 20 mL of 70% ethanol.d.Place magnetic stirrer bar in an ethanol-containing vessel and put it for 5 min on a magnetic stirrer.e.Transfer magnetic stirrer bar to vessel filled with 50 mL of MilliQ water (step 8b), and put it back on a magnetic stirrer. Repeat this twice.f.Transfer magnetic stirrer bar to the vessel with 20 mL of MilliQ water (step 8b). It is ready to use. Prepare magnetic stirrer and magnetic stirrer bar.a.Filter MilliQ water (120 mL) under the laminar flow chamber.b.Transfer 50 mL of MilliQ water to two sterile vessels with flat bottom. Transfer 20 mL of MilliQ water to the third vessel.c.Fill another 1 flat bottom vessel with 20 mL of 70% ethanol.d.Place magnetic stirrer bar in an ethanol-containing vessel and put it for 5 min on a magnetic stirrer.e.Transfer magnetic stirrer bar to vessel filled with 50 mL of MilliQ water (step 8b), and put it back on a magnetic stirrer. Repeat this twice.f.Transfer magnetic stirrer bar to the vessel with 20 mL of MilliQ water (step 8b). It is ready to use. a.Filter MilliQ water (120 mL) under the laminar flow chamber. Filter MilliQ water (120 mL) under the laminar flow chamber. b.Transfer 50 mL of MilliQ water to two sterile vessels with flat bottom. Transfer 20 mL of MilliQ water to the third vessel. Transfer 50 mL of MilliQ water to two sterile vessels with flat bottom. Transfer 20 mL of MilliQ water to the third vessel. c.Fill another 1 flat bottom vessel with 20 mL of 70% ethanol. Fill another 1 flat bottom vessel with 20 mL of 70% ethanol. d.Place magnetic stirrer bar in an ethanol-containing vessel and put it for 5 min on a magnetic stirrer. Place magnetic stirrer bar in an ethanol-containing vessel and put it for 5 min on a magnetic stirrer. e.Transfer magnetic stirrer bar to vessel filled with 50 mL of MilliQ water (step 8b), and put it back on a magnetic stirrer. Repeat this twice. Transfer magnetic stirrer bar to vessel filled with 50 mL of MilliQ water (step 8b), and put it back on a magnetic stirrer. Repeat this twice. f.Transfer magnetic stirrer bar to the vessel with 20 mL of MilliQ water (step 8b). It is ready to use. Transfer magnetic stirrer bar to the vessel with 20 mL of MilliQ water (step 8b). It is ready to use. 9.Prepare Multidrop for work.a.Rinse the device cassette with 5 mL of MilliQ water.b.Rinse the cassette with 5 mL of 70% ethanol.c.Rinse it one more time with 5 mL of MilliQ water. Prepare Multidrop for work.a.Rinse the device cassette with 5 mL of MilliQ water.b.Rinse the cassette with 5 mL of 70% ethanol.c.Rinse it one more time with 5 mL of MilliQ water. a.Rinse the device cassette with 5 mL of MilliQ water. Rinse the device cassette with 5 mL of MilliQ water. b.Rinse the cassette with 5 mL of 70% ethanol. Rinse the cassette with 5 mL of 70% ethanol. c.Rinse it one more time with 5 mL of MilliQ water. Rinse it one more time with 5 mL of MilliQ water. 10.Fill the columns 1–3 and 22–24 with 20 μL of Opti-MEM medium. Fill the columns 1–3 and 22–24 with 20 μL of Opti-MEM medium. CRITICAL: Before dispensing reagents with Multidrop perform priming to make sure its cassette is filled with them. 11.Prepare transfection mixture. To transfect six 384-well plates (columns 4–21), prepare 12.12 mL of it.a.Add 12 mL of Opti-MEM medium to 50 mL tube.b.Add 120 μL of RNAiMAX transfection reagent.c.Mix slowly few times. Prepare transfection mixture. To transfect six 384-well plates (columns 4–21), prepare 12.12 mL of it.a.Add 12 mL of Opti-MEM medium to 50 mL tube.b.Add 120 μL of RNAiMAX transfection reagent.c.Mix slowly few times. a.Add 12 mL of Opti-MEM medium to 50 mL tube. Add 12 mL of Opti-MEM medium to 50 mL tube. b.Add 120 μL of RNAiMAX transfection reagent. Add 120 μL of RNAiMAX transfection reagent. c.Mix slowly few times. Mix slowly few times. 12.Add 5 μL of the transfection mixture to columns 4–21 of assay plates (already containing 5 μL of siRNA; step 4b). Add 5 μL of the transfection mixture to columns 4–21 of assay plates (already containing 5 μL of siRNA; step 4b). CRITICAL: After adding transfection agent to assay plates, seed cells within 40 min. Do not allow RNAiMAX for longer incubation with siRNA only, as it may affect transfection efficiency. 13.Trypsinize HeLa cells from 10 cm dish prepared a day before transfection (follow standard lab procedure).a.Pre-warm sterile PBS, trypsin-EDTA and complete IMDM medium at 37°C in a water bath.b.Aspirate the culture medium from the plate.c.Wash the cells monolayer with 5 ml of sterile PBS.d.Add pre-warmed trypsin-EDTA solution in PBS (0.5 ml of trypsin-EDTA in 1.5 ml of PBS) to cells.e.Incubate at 37°C for 5 to 10 min.f.Add 3 ml of complete IMDM medium to the plate. Trypsinize HeLa cells from 10 cm dish prepared a day before transfection (follow standard lab procedure).a.Pre-warm sterile PBS, trypsin-EDTA and complete IMDM medium at 37°C in a water bath.b.Aspirate the culture medium from the plate.c.Wash the cells monolayer with 5 ml of sterile PBS.d.Add pre-warmed trypsin-EDTA solution in PBS (0.5 ml of trypsin-EDTA in 1.5 ml of PBS) to cells.e.Incubate at 37°C for 5 to 10 min.f.Add 3 ml of complete IMDM medium to the plate. a.Pre-warm sterile PBS, trypsin-EDTA and complete IMDM medium at 37°C in a water bath. Pre-warm sterile PBS, trypsin-EDTA and complete IMDM medium at 37°C in a water bath. b.Aspirate the culture medium from the plate. Aspirate the culture medium from the plate. c.Wash the cells monolayer with 5 ml of sterile PBS. Wash the cells monolayer with 5 ml of sterile PBS. d.Add pre-warmed trypsin-EDTA solution in PBS (0.5 ml of trypsin-EDTA in 1.5 ml of PBS) to cells. Add pre-warmed trypsin-EDTA solution in PBS (0.5 ml of trypsin-EDTA in 1.5 ml of PBS) to cells. e.Incubate at 37°C for 5 to 10 min. Incubate at 37°C for 5 to 10 min. f.Add 3 ml of complete IMDM medium to the plate. Add 3 ml of complete IMDM medium to the plate. 14.Take 1/5 of detached cells (1 mL) and seed them in fresh 10 cm dish (cells growth control). Take 1/5 of detached cells (1 mL) and seed them in fresh 10 cm dish (cells growth control). 15.Take another 1/5 of detached cells (1 mL), and pipette them through a 5 mL tube with a strainer in a cap to remove cell aggregates. Take another 1/5 of detached cells (1 mL), and pipette them through a 5 mL tube with a strainer in a cap to remove cell aggregates. 16.Transfer 500 μL of cells suspension to 1.5 mL tube and count cells 4 times e.g., in a Thoma chamber. Transfer 500 μL of cells suspension to 1.5 mL tube and count cells 4 times e.g., in a Thoma chamber. Note: Consider if cells dilution is needed for accurate counting. 17.Prepare 100 mL of cell mixture of final concentration 2 × 104 cells/mL. Prepare 100 mL of cell mixture of final concentration 2 × 104 cells/mL. 18.Place the cell mixture on a magnetic stirrer, carefully put a magnetic stirrer bar in the cell mixture. Set a gentle mixing. Place the cell mixture on a magnetic stirrer, carefully put a magnetic stirrer bar in the cell mixture. Set a gentle mixing. 19.Dispense 40 μL of cells mixture to siRNA/transfection mixture containing columns 4–21 of 384-well assay plates with Multidrop. It results in putting 800 cell/well for transfected wells. Dispense 40 μL of cells mixture to siRNA/transfection mixture containing columns 4–21 of 384-well assay plates with Multidrop. It results in putting 800 cell/well for transfected wells. 20.Dispense 25 μL of cells mixture to columns 1–3 and 22–24. It results in putting 500 cell/well for non-transfected wells. Dispense 25 μL of cells mixture to columns 1–3 and 22–24. It results in putting 500 cell/well for non-transfected wells. Note: Final siRNA concentration in the screening is 11 nM. Note: The number of cells used for transfection must be established experimentally. It depends on cells doubling-time, selected time of culture after transfection and sensitivity of cells to the transfection procedure. Note: To limit media evaporation from experimental wells and to avoid an extra step of adding media alone, we fill columns 1–2 and 23–24 with a cell mixture. These columns are not stained later and are excluded from data collection. Optional: For cells sensitive to transfection, account for transfection-induced cell death and calculate pyroptosis-specific cell death by using parts of columns 1–3 and 22–24 (e.g., columns 3 and 22) to evaluate baseline cell death. Dispense 40 μL of the cell mixture into a mock transfection mixture (prepared per step 11, without siRNA) in the designated columns of 384-well assay plates using a Multidrop dispenser. This dispenses 800 cells/well for transfected wells. If you use columns 3 and 22 for background cell death, shift the position of the growth control columns (e.g., to columns 2 and 23). 21.Incubate plates for 1 h at 22°C under the laminar flow chamber. Incubate plates for 1 h at 22°C under the laminar flow chamber. 22.Transfer plates to cell culture incubator (37°C, 5% CO2) keep them individually for 1 h and then stack them. Transfer plates to cell culture incubator (37°C, 5% CO2) keep them individually for 1 h and then stack them. 23.Incubate plates in the incubator for 36 h. Incubate plates in the incubator for 36 h. Stimulation with interferon-γ Timing: 2 h Timing: 2 h In this step, prime cells with IFN-γ to stimulate expression of ISGs, which are necessary for noncanonical inflammasome formation and cell death.Note: Due to the IncuCyte S3 workflow, do not stimulate more than two 384-well plates at the same time.24.Prepare IFN-γ solution in complete IMDM medium. Stock solution is 100 μg/mL. Prime epithelial cells with IFN-γ solution at concentration of 11 ng/mL (the final concentration of IFN-γ in experiment is 1 ng/mL).Note: Different cell lines may show different IFN-γ sensitivity. Before the screening, determine working IFN-γ concentration.Note: IFN-γ may induce cell death in some cell lines. Before the screening, determine the background cell death induced by the IFN-γ treatment.a.Prepare intermediate dilution (100 ng/mL).i.Dilute stock solution 1000 times.ii.Mix thoroughly.b.Prepare the final IFN-γ solution (11 ng/mL). To stimulate two plates, prepare 6 mL of this mixture.i.Take 5.34 mL of complete IMDM medium.ii.Add 660 μL of intermediate IFN-γ solution.iii.Mix thoroughly.25.Take 1 mL from prepared solution and transfer it to the 1.5 mL tube.26.Prepare Multidrop for work.a.Rinse the device cassette with 5 mL of MilliQ water.b.Rinse the cassette with 5 mL of 70% ethanol.c.Rinse it one more time with 5 mL of MilliQ water.27.Add manually IFN-γ to the columns 4 and 21 (rows G-O). Consider the usage of an electronic pipette. Add 5 μL/well of IFN-γ solution (medium speed in electronic pipette) (Figure 1B).28.Using Multidrop add 5 μL of IFN-γ solution to columns 5–20 (Figure 1B).29.Add 5 μl/well of complete IMDM medium to columns 3, 22 and 4, 21 (rows B-F).30.Wait 30 min and repeat steps 24–29 for another two assay plates.31.Transfer plates to cell culture incubator – 37°C, 5% CO2. Incubate them for additional 12 h. Note: Due to the IncuCyte S3 workflow, do not stimulate more than two 384-well plates at the same time. 24.Prepare IFN-γ solution in complete IMDM medium. Stock solution is 100 μg/mL. Prime epithelial cells with IFN-γ solution at concentration of 11 ng/mL (the final concentration of IFN-γ in experiment is 1 ng/mL).Note: Different cell lines may show different IFN-γ sensitivity. Before the screening, determine working IFN-γ concentration.Note: IFN-γ may induce cell death in some cell lines. Before the screening, determine the background cell death induced by the IFN-γ treatment.a.Prepare intermediate dilution (100 ng/mL).i.Dilute stock solution 1000 times.ii.Mix thoroughly.b.Prepare the final IFN-γ solution (11 ng/mL). To stimulate two plates, prepare 6 mL of this mixture.i.Take 5.34 mL of complete IMDM medium.ii.Add 660 μL of intermediate IFN-γ solution.iii.Mix thoroughly. Prepare IFN-γ solution in complete IMDM medium. Stock solution is 100 μg/mL. Prime epithelial cells with IFN-γ solution at concentration of 11 ng/mL (the final concentration of IFN-γ in experiment is 1 ng/mL).Note: Different cell lines may show different IFN-γ sensitivity. Before the screening, determine working IFN-γ concentration.Note: IFN-γ may induce cell death in some cell lines. Before the screening, determine the background cell death induced by the IFN-γ treatment.a.Prepare intermediate dilution (100 ng/mL).i.Dilute stock solution 1000 times.ii.Mix thoroughly.b.Prepare the final IFN-γ solution (11 ng/mL). To stimulate two plates, prepare 6 mL of this mixture.i.Take 5.34 mL of complete IMDM medium.ii.Add 660 μL of intermediate IFN-γ solution.iii.Mix thoroughly. Note: Different cell lines may show different IFN-γ sensitivity. Before the screening, determine working IFN-γ concentration. Note: IFN-γ may induce cell death in some cell lines. Before the screening, determine the background cell death induced by the IFN-γ treatment. a.Prepare intermediate dilution (100 ng/mL).i.Dilute stock solution 1000 times.ii.Mix thoroughly. Prepare intermediate dilution (100 ng/mL).i.Dilute stock solution 1000 times.ii.Mix thoroughly. i.Dilute stock solution 1000 times. Dilute stock solution 1000 times. ii.Mix thoroughly. Mix thoroughly. b.Prepare the final IFN-γ solution (11 ng/mL). To stimulate two plates, prepare 6 mL of this mixture.i.Take 5.34 mL of complete IMDM medium.ii.Add 660 μL of intermediate IFN-γ solution.iii.Mix thoroughly. Prepare the final IFN-γ solution (11 ng/mL). To stimulate two plates, prepare 6 mL of this mixture.i.Take 5.34 mL of complete IMDM medium.ii.Add 660 μL of intermediate IFN-γ solution.iii.Mix thoroughly. i.Take 5.34 mL of complete IMDM medium. Take 5.34 mL of complete IMDM medium. ii.Add 660 μL of intermediate IFN-γ solution. Add 660 μL of intermediate IFN-γ solution. iii.Mix thoroughly. Mix thoroughly. 25.Take 1 mL from prepared solution and transfer it to the 1.5 mL tube. Take 1 mL from prepared solution and transfer it to the 1.5 mL tube. 26.Prepare Multidrop for work.a.Rinse the device cassette with 5 mL of MilliQ water.b.Rinse the cassette with 5 mL of 70% ethanol.c.Rinse it one more time with 5 mL of MilliQ water. Prepare Multidrop for work.a.Rinse the device cassette with 5 mL of MilliQ water.b.Rinse the cassette with 5 mL of 70% ethanol.c.Rinse it one more time with 5 mL of MilliQ water. a.Rinse the device cassette with 5 mL of MilliQ water. Rinse the device cassette with 5 mL of MilliQ water. b.Rinse the cassette with 5 mL of 70% ethanol. Rinse the cassette with 5 mL of 70% ethanol. c.Rinse it one more time with 5 mL of MilliQ water. Rinse it one more time with 5 mL of MilliQ water. 27.Add manually IFN-γ to the columns 4 and 21 (rows G-O). Consider the usage of an electronic pipette. Add 5 μL/well of IFN-γ solution (medium speed in electronic pipette) (Figure 1B). Add manually IFN-γ to the columns 4 and 21 (rows G-O). Consider the usage of an electronic pipette. Add 5 μL/well of IFN-γ solution (medium speed in electronic pipette) (Figure 1B). 28.Using Multidrop add 5 μL of IFN-γ solution to columns 5–20 (Figure 1B). Using Multidrop add 5 μL of IFN-γ solution to columns 5–20 (Figure 1B). 29.Add 5 μl/well of complete IMDM medium to columns 3, 22 and 4, 21 (rows B-F). Add 5 μl/well of complete IMDM medium to columns 3, 22 and 4, 21 (rows B-F). 30.Wait 30 min and repeat steps 24–29 for another two assay plates. Wait 30 min and repeat steps 24–29 for another two assay plates. 31.Transfer plates to cell culture incubator – 37°C, 5% CO2. Incubate them for additional 12 h. Transfer plates to cell culture incubator – 37°C, 5% CO2. Incubate them for additional 12 h. LPS transfection, fluorescent staining, and data visualization Timing: 8 h Timing: 8 h In this step, transfect HeLa epithelial cells with bacterial LPS, which triggers noncanonical inflammasome formation. This leads to highly inflammatory cell death – pyroptosis. To visualize this effect, stain cells with two fluorescent dyes – SYTO 9 Green (cell-permeant dye staining nucleic acids of all cells) and propidium iodide (PI – cell-impermeant dye staining nucleic acids of only membrane-compromised dying cells) and examine nuclear staining using live-cell microscopy at IncuCyte S3 imaging system. Capture fluorescence images at baseline and 5 h post-induction and automatically quantify green and red cell counts to yield a pyroptosis ratio for each gene knockdown.CRITICAL: To obtain reliable results of the screening, cells cannot be fixed before visualization.Note: Due to the IncuCyte S3 work pattern transfect each plate with LPS separately. It takes 12 min to scan one plate and a 10-min break should be introduced after each scan to allow machine to cool down and avoid overheating of cells.Alternatives: Depending on available fluorescent channels, different dyes than SYTO™ 9 Green or PI can be used. For instance, SYTO 9 Green can be replaced with Hoechst and instead of PI, cell-impermeant dyes, such as 7-Aminoactinomycin D (7-AAD) or members of SYTOX family (Thermo Fisher) can be applied.32.Prepare the transfection mixture (solution of LPS with a transfection reagent) as outlined in materials and equipment section.Note: Different cell lines may show different LPS sensitivity. Before the screening, determine pyroptosis-inducing LPS concentration.33.Incubate transfection mixture for 30 min at 22°C.Note: Once 20 min of incubation passes, start preparing another transfection mixture.34.Prepare Multidrop for work.a.Rinse the device cassette with 5 mL of MilliQ water.b.Rinse the cassette with 5 mL of 70% ethanol.c.Rinse it one more time with 5 mL of MilliQ water.35.While incubating LPS transfection solution, prepare Fluorescent dyes solution as outlined in materials and equipment section. To stain six 384-well assay plates 22 ml of dye solution is needed.36.Use Multidrop™ to dispense 10 μL of Fluorescent dyes solution per well to columns 3–22.37.After completing the incubation at step 33 add 10 μL of LPS transfection solution per well to columns 4–21.Note: You can use Multidrop for LPS transfection.38.Scan plate in the IncuCyte S3.a.Carefully place a plate in the device.b.Set a program to scan a plate (Figure 2).i.In first pop-up window choose “Schedule To Acquire”.ii.In the upper left corner click on the plus sign (“Launch Add Vessel”).iii.A pop-up window appears. “Scan Repeatedly or Once?” - Choose “Scan on Schedule” and “Next”.iv.Create or Restore Vessel – choose “New” and click on “Next”.v.Scan Type – choose “Standard” and “Next”.vi.Scan Settings - Choose “Green” and “Red” fluorescence channels as well “phase” channel, objective: “10X” magnification and “Next”.vii.Vessel Selection – choose Greiner 384-well plate cat.#781946 and “Next”.viii.Vessel Location – choose the location of a plate in the machine and “Next”.ix.Scan Pattern – choose wells to be visualized (columns: 3–22; rows B-O) and “Next”.x.Vessel Notebook – enter the plate label (name) and “Next”.xi.Analysis Setup – “Defer analysis until later” and “Next”.xii.Scan Schedule – choose “Create new schedule with advanced scheduling options” and manually enter scans timing (0 and 5 h post transfection) and “Next”.xiii.Summary – check if all the settings are correct and click “Add to Schedule”.Figure 2Workflow in the IncuCyte S3Example of a scan setting-up.c.Scan plate in time 0 h after transfection (growth control) and 5 h post LPS transfection (cell death analysis).d.Set a scan analysis (Figure 3; Table 1).Note: Analysis definition is created by each user individually. One analysis pipeline can be used for as many scans as the user wishes to.i.Once the window with experimental images is open, choose “Launch Analysis” on the left side.ii.Pop-up window appears with the question whether you want to continue without defining Spectral Unmixing - click “Yes”.iii.New or Use Existing Analysis Definition – choose “Create New Analysis definition” and “Next”.iv.Analysis Type – Select “Basic Analyzer” and “Next”.v.Image Channels – Select “Green” and “Red” – and “Next”.vi.Image Set Selection – select images that will be preview to define the analysis. Choose images from negative and positive control set and “Next”.vii.Analysis Definition – setting needs to be chosen individually. For point of reference Analysis definition used in this protocol is shown in Table 1. Once the set-up is done click on “Next”.viii.Scan Times and Wells – select time points (0 and 5 h) and wells that will be analyzed (rows B-O, columns 3–22) and “Next”.ix.Save and Apply Analysis Definition – name your analysis and “Next”.x.Summary – check details of your analysis and click “Finish”.Figure 3Workflow in the IncuCyte S3Example of an analysis set-up.Table 1Details of analysis definition used in the siRNA screeningAnalysis definitionGreenRedSegmentation (Top-Hat)Radius (μM)100,00Radius (μM)100,00Threshold (GCU)15,00Threshold (GCU)0,400Edge Split On (Edge Sensitivity)−20Edge Split On (Edge Sensitivity)−30CleanupHole Fill (μM2)150,00Hole Fill (μM2)0,00Adjust Size (pixels)−2Adjust Size (pixels)0Filters (only applied)Area (μM2)min. 15,00Area (μM2)min. 50,0039.Collect your data from IncuCyte S3 Software (Figure 4).a.Open Analysis Definition panel for your images.b.Choose Graph Metrics on the left side.c.Choose “Green Count (Per Image)”, select scans and wells for which you export data and click on “Export Data”.Note: Green Count represents SYTO™ 9 Green positive cells.d.Select the destination of the file, name exported file.e.Click on “Export”.f.Repeat steps 37.b-e for PI-positive cells (“Red Count (Per Image)”).Note: Exported data are in.txt files. To calculate ratio of PI-positive cells to SYTO 9 positive we recommend to use Microsoft-Excel spreadsheets or R.Note: Instructions presented on Figures 2, 3, and 4 are screenshots of analysis software version v2019B.Note: Verify implemented analysis manually to ensure that only true cell death events are counted.Figure 4Workflow in the IncuCyte S3Export of the experimental data. CRITICAL: To obtain reliable results of the screening, cells cannot be fixed before visualization. Note: Due to the IncuCyte S3 work pattern transfect each plate with LPS separately. It takes 12 min to scan one plate and a 10-min break should be introduced after each scan to allow machine to cool down and avoid overheating of cells. Alternatives: Depending on available fluorescent channels, different dyes than SYTO™ 9 Green or PI can be used. For instance, SYTO 9 Green can be replaced with Hoechst and instead of PI, cell-impermeant dyes, such as 7-Aminoactinomycin D (7-AAD) or members of SYTOX family (Thermo Fisher) can be applied. 32.Prepare the transfection mixture (solution of LPS with a transfection reagent) as outlined in materials and equipment section. Prepare the transfection mixture (solution of LPS with a transfection reagent) as outlined in materials and equipment section. Note: Different cell lines may show different LPS sensitivity. Before the screening, determine pyroptosis-inducing LPS concentration. 33.Incubate transfection mixture for 30 min at 22°C. Incubate transfection mixture for 30 min at 22°C. Note: Once 20 min of incubation passes, start preparing another transfection mixture. 34.Prepare Multidrop for work.a.Rinse the device cassette with 5 mL of MilliQ water.b.Rinse the cassette with 5 mL of 70% ethanol.c.Rinse it one more time with 5 mL of MilliQ water. Prepare Multidrop for work.a.Rinse the device cassette with 5 mL of MilliQ water.b.Rinse the cassette with 5 mL of 70% ethanol.c.Rinse it one more time with 5 mL of MilliQ water. a.Rinse the device cassette with 5 mL of MilliQ water. Rinse the device cassette with 5 mL of MilliQ water. b.Rinse the cassette with 5 mL of 70% ethanol. Rinse the cassette with 5 mL of 70% ethanol. c.Rinse it one more time with 5 mL of MilliQ water. Rinse it one more time with 5 mL of MilliQ water. 35.While incubating LPS transfection solution, prepare Fluorescent dyes solution as outlined in materials and equipment section. To stain six 384-well assay plates 22 ml of dye solution is needed. While incubating LPS transfection solution, prepare Fluorescent dyes solution as outlined in materials and equipment section. To stain six 384-well assay plates 22 ml of dye solution is needed. 36.Use Multidrop™ to dispense 10 μL of Fluorescent dyes solution per well to columns 3–22. Use Multidrop™ to dispense 10 μL of Fluorescent dyes solution per well to columns 3–22. 37.After completing the incubation at step 33 add 10 μL of LPS transfection solution per well to columns 4–21. After completing the incubation at step 33 add 10 μL of LPS transfection solution per well to columns 4–21. Note: You can use Multidrop for LPS transfection. 38.Scan plate in the IncuCyte S3.a.Carefully place a plate in the device.b.Set a program to scan a plate (Figure 2).i.In first pop-up window choose “Schedule To Acquire”.ii.In the upper left corner click on the plus sign (“Launch Add Vessel”).iii.A pop-up window appears. “Scan Repeatedly or Once?” - Choose “Scan on Schedule” and “Next”.iv.Create or Restore Vessel – choose “New” and click on “Next”.v.Scan Type – choose “Standard” and “Next”.vi.Scan Settings - Choose “Green” and “Red” fluorescence channels as well “phase” channel, objective: “10X” magnification and “Next”.vii.Vessel Selection – choose Greiner 384-well plate cat.#781946 and “Next”.viii.Vessel Location – choose the location of a plate in the machine and “Next”.ix.Scan Pattern – choose wells to be visualized (columns: 3–22; rows B-O) and “Next”.x.Vessel Notebook – enter the plate label (name) and “Next”.xi.Analysis Setup – “Defer analysis until later” and “Next”.xii.Scan Schedule – choose “Create new schedule with advanced scheduling options” and manually enter scans timing (0 and 5 h post transfection) and “Next”.xiii.Summary – check if all the settings are correct and click “Add to Schedule”.Figure 2Workflow in the IncuCyte S3Example of a scan setting-up.c.Scan plate in time 0 h after transfection (growth control) and 5 h post LPS transfection (cell death analysis).d.Set a scan analysis (Figure 3; Table 1).Note: Analysis definition is created by each user individually. One analysis pipeline can be used for as many scans as the user wishes to.i.Once the window with experimental images is open, choose “Launch Analysis” on the left side.ii.Pop-up window appears with the question whether you want to continue without defining Spectral Unmixing - click “Yes”.iii.New or Use Existing Analysis Definition – choose “Create New Analysis definition” and “Next”.iv.Analysis Type – Select “Basic Analyzer” and “Next”.v.Image Channels – Select “Green” and “Red” – and “Next”.vi.Image Set Selection – select images that will be preview to define the analysis. Choose images from negative and positive control set and “Next”.vii.Analysis Definition – setting needs to be chosen individually. For point of reference Analysis definition used in this protocol is shown in Table 1. Once the set-up is done click on “Next”.viii.Scan Times and Wells – select time points (0 and 5 h) and wells that will be analyzed (rows B-O, columns 3–22) and “Next”.ix.Save and Apply Analysis Definition – name your analysis and “Next”.x.Summary – check details of your analysis and click “Finish”.Figure 3Workflow in the IncuCyte S3Example of an analysis set-up.Table 1Details of analysis definition used in the siRNA screeningAnalysis definitionGreenRedSegmentation (Top-Hat)Radius (μM)100,00Radius (μM)100,00Threshold (GCU)15,00Threshold (GCU)0,400Edge Split On (Edge Sensitivity)−20Edge Split On (Edge Sensitivity)−30CleanupHole Fill (μM2)150,00Hole Fill (μM2)0,00Adjust Size (pixels)−2Adjust Size (pixels)0Filters (only applied)Area (μM2)min. 15,00Area (μM2)min. 50,00 Scan plate in the IncuCyte S3.a.Carefully place a plate in the device.b.Set a program to scan a plate (Figure 2).i.In first pop-up window choose “Schedule To Acquire”.ii.In the upper left corner click on the plus sign (“Launch Add Vessel”).iii.A pop-up window appears. “Scan Repeatedly or Once?” - Choose “Scan on Schedule” and “Next”.iv.Create or Restore Vessel – choose “New” and click on “Next”.v.Scan Type – choose “Standard” and “Next”.vi.Scan Settings - Choose “Green” and “Red” fluorescence channels as well “phase” channel, objective: “10X” magnification and “Next”.vii.Vessel Selection – choose Greiner 384-well plate cat.#781946 and “Next”.viii.Vessel Location – choose the location of a plate in the machine and “Next”.ix.Scan Pattern – choose wells to be visualized (columns: 3–22; rows B-O) and “Next”.x.Vessel Notebook – enter the plate label (name) and “Next”.xi.Analysis Setup – “Defer analysis until later” and “Next”.xii.Scan Schedule – choose “Create new schedule with advanced scheduling options” and manually enter scans timing (0 and 5 h post transfection) and “Next”.xiii.Summary – check if all the settings are correct and click “Add to Schedule”.Figure 2Workflow in the IncuCyte S3Example of a scan setting-up.c.Scan plate in time 0 h after transfection (growth control) and 5 h post LPS transfection (cell death analysis).d.Set a scan analysis (Figure 3; Table 1).Note: Analysis definition is created by each user individually. One analysis pipeline can be used for as many scans as the user wishes to.i.Once the window with experimental images is open, choose “Launch Analysis” on the left side.ii.Pop-up window appears with the question whether you want to continue without defining Spectral Unmixing - click “Yes”.iii.New or Use Existing Analysis Definition – choose “Create New Analysis definition” and “Next”.iv.Analysis Type – Select “Basic Analyzer” and “Next”.v.Image Channels – Select “Green” and “Red” – and “Next”.vi.Image Set Selection – select images that will be preview to define the analysis. Choose images from negative and positive control set and “Next”.vii.Analysis Definition – setting needs to be chosen individually. For point of reference Analysis definition used in this protocol is shown in Table 1. Once the set-up is done click on “Next”.viii.Scan Times and Wells – select time points (0 and 5 h) and wells that will be analyzed (rows B-O, columns 3–22) and “Next”.ix.Save and Apply Analysis Definition – name your analysis and “Next”.x.Summary – check details of your analysis and click “Finish”.Figure 3Workflow in the IncuCyte S3Example of an analysis set-up.Table 1Details of analysis definition used in the siRNA screeningAnalysis definitionGreenRedSegmentation (Top-Hat)Radius (μM)100,00Radius (μM)100,00Threshold (GCU)15,00Threshold (GCU)0,400Edge Split On (Edge Sensitivity)−20Edge Split On (Edge Sensitivity)−30CleanupHole Fill (μM2)150,00Hole Fill (μM2)0,00Adjust Size (pixels)−2Adjust Size (pixels)0Filters (only applied)Area (μM2)min. 15,00Area (μM2)min. 50,00 a.Carefully place a plate in the device. Carefully place a plate in the device. b.Set a program to scan a plate (Figure 2).i.In first pop-up window choose “Schedule To Acquire”.ii.In the upper left corner click on the plus sign (“Launch Add Vessel”).iii.A pop-up window appears. “Scan Repeatedly or Once?” - Choose “Scan on Schedule” and “Next”.iv.Create or Restore Vessel – choose “New” and click on “Next”.v.Scan Type – choose “Standard” and “Next”.vi.Scan Settings - Choose “Green” and “Red” fluorescence channels as well “phase” channel, objective: “10X” magnification and “Next”.vii.Vessel Selection – choose Greiner 384-well plate cat.#781946 and “Next”.viii.Vessel Location – choose the location of a plate in the machine and “Next”.ix.Scan Pattern – choose wells to be visualized (columns: 3–22; rows B-O) and “Next”.x.Vessel Notebook – enter the plate label (name) and “Next”.xi.Analysis Setup – “Defer analysis until later” and “Next”.xii.Scan Schedule – choose “Create new schedule with advanced scheduling options” and manually enter scans timing (0 and 5 h post transfection) and “Next”.xiii.Summary – check if all the settings are correct and click “Add to Schedule”.Figure 2Workflow in the IncuCyte S3Example of a scan setting-up. Set a program to scan a plate (Figure 2).i.In first pop-up window choose “Schedule To Acquire”.ii.In the upper left corner click on the plus sign (“Launch Add Vessel”).iii.A pop-up window appears. “Scan Repeatedly or Once?” - Choose “Scan on Schedule” and “Next”.iv.Create or Restore Vessel – choose “New” and click on “Next”.v.Scan Type – choose “Standard” and “Next”.vi.Scan Settings - Choose “Green” and “Red” fluorescence channels as well “phase” channel, objective: “10X” magnification and “Next”.vii.Vessel Selection – choose Greiner 384-well plate cat.#781946 and “Next”.viii.Vessel Location – choose the location of a plate in the machine and “Next”.ix.Scan Pattern – choose wells to be visualized (columns: 3–22; rows B-O) and “Next”.x.Vessel Notebook – enter the plate label (name) and “Next”.xi.Analysis Setup – “Defer analysis until later” and “Next”.xii.Scan Schedule – choose “Create new schedule with advanced scheduling options” and manually enter scans timing (0 and 5 h post transfection) and “Next”.xiii.Summary – check if all the settings are correct and click “Add to Schedule”.Figure 2Workflow in the IncuCyte S3Example of a scan setting-up. i.In first pop-up window choose “Schedule To Acquire”. In first pop-up window choose “Schedule To Acquire”. ii.In the upper left corner click on the plus sign (“Launch Add Vessel”). In the upper left corner click on the plus sign (“Launch Add Vessel”). iii.A pop-up window appears. “Scan Repeatedly or Once?” - Choose “Scan on Schedule” and “Next”. A pop-up window appears. “Scan Repeatedly or Once?” - Choose “Scan on Schedule” and “Next”. iv.Create or Restore Vessel – choose “New” and click on “Next”. Create or Restore Vessel – choose “New” and click on “Next”. v.Scan Type – choose “Standard” and “Next”. Scan Type – choose “Standard” and “Next”. vi.Scan Settings - Choose “Green” and “Red” fluorescence channels as well “phase” channel, objective: “10X” magnification and “Next”. Scan Settings - Choose “Green” and “Red” fluorescence channels as well “phase” channel, objective: “10X” magnification and “Next”. vii.Vessel Selection – choose Greiner 384-well plate cat.#781946 and “Next”. Vessel Selection – choose Greiner 384-well plate cat.#781946 and “Next”. viii.Vessel Location – choose the location of a plate in the machine and “Next”. Vessel Location – choose the location of a plate in the machine and “Next”. ix.Scan Pattern – choose wells to be visualized (columns: 3–22; rows B-O) and “Next”. Scan Pattern – choose wells to be visualized (columns: 3–22; rows B-O) and “Next”. x.Vessel Notebook – enter the plate label (name) and “Next”. Vessel Notebook – enter the plate label (name) and “Next”. xi.Analysis Setup – “Defer analysis until later” and “Next”. Analysis Setup – “Defer analysis until later” and “Next”. xii.Scan Schedule – choose “Create new schedule with advanced scheduling options” and manually enter scans timing (0 and 5 h post transfection) and “Next”. Scan Schedule – choose “Create new schedule with advanced scheduling options” and manually enter scans timing (0 and 5 h post transfection) and “Next”. xiii.Summary – check if all the settings are correct and click “Add to Schedule”. Summary – check if all the settings are correct and click “Add to Schedule”. Workflow in the IncuCyte S3 Example of a scan setting-up. c.Scan plate in time 0 h after transfection (growth control) and 5 h post LPS transfection (cell death analysis). Scan plate in time 0 h after transfection (growth control) and 5 h post LPS transfection (cell death analysis). d.Set a scan analysis (Figure 3; Table 1).Note: Analysis definition is created by each user individually. One analysis pipeline can be used for as many scans as the user wishes to.i.Once the window with experimental images is open, choose “Launch Analysis” on the left side.ii.Pop-up window appears with the question whether you want to continue without defining Spectral Unmixing - click “Yes”.iii.New or Use Existing Analysis Definition – choose “Create New Analysis definition” and “Next”.iv.Analysis Type – Select “Basic Analyzer” and “Next”.v.Image Channels – Select “Green” and “Red” – and “Next”.vi.Image Set Selection – select images that will be preview to define the analysis. Choose images from negative and positive control set and “Next”.vii.Analysis Definition – setting needs to be chosen individually. For point of reference Analysis definition used in this protocol is shown in Table 1. Once the set-up is done click on “Next”.viii.Scan Times and Wells – select time points (0 and 5 h) and wells that will be analyzed (rows B-O, columns 3–22) and “Next”.ix.Save and Apply Analysis Definition – name your analysis and “Next”.x.Summary – check details of your analysis and click “Finish”.Figure 3Workflow in the IncuCyte S3Example of an analysis set-up.Table 1Details of analysis definition used in the siRNA screeningAnalysis definitionGreenRedSegmentation (Top-Hat)Radius (μM)100,00Radius (μM)100,00Threshold (GCU)15,00Threshold (GCU)0,400Edge Split On (Edge Sensitivity)−20Edge Split On (Edge Sensitivity)−30CleanupHole Fill (μM2)150,00Hole Fill (μM2)0,00Adjust Size (pixels)−2Adjust Size (pixels)0Filters (only applied)Area (μM2)min. 15,00Area (μM2)min. 50,00 Set a scan analysis (Figure 3; Table 1).Note: Analysis definition is created by each user individually. One analysis pipeline can be used for as many scans as the user wishes to.i.Once the window with experimental images is open, choose “Launch Analysis” on the left side.ii.Pop-up window appears with the question whether you want to continue without defining Spectral Unmixing - click “Yes”.iii.New or Use Existing Analysis Definition – choose “Create New Analysis definition” and “Next”.iv.Analysis Type – Select “Basic Analyzer” and “Next”.v.Image Channels – Select “Green” and “Red” – and “Next”.vi.Image Set Selection – select images that will be preview to define the analysis. Choose images from negative and positive control set and “Next”.vii.Analysis Definition – setting needs to be chosen individually. For point of reference Analysis definition used in this protocol is shown in Table 1. Once the set-up is done click on “Next”.viii.Scan Times and Wells – select time points (0 and 5 h) and wells that will be analyzed (rows B-O, columns 3–22) and “Next”.ix.Save and Apply Analysis Definition – name your analysis and “Next”.x.Summary – check details of your analysis and click “Finish”.Figure 3Workflow in the IncuCyte S3Example of an analysis set-up.Table 1Details of analysis definition used in the siRNA screeningAnalysis definitionGreenRedSegmentation (Top-Hat)Radius (μM)100,00Radius (μM)100,00Threshold (GCU)15,00Threshold (GCU)0,400Edge Split On (Edge Sensitivity)−20Edge Split On (Edge Sensitivity)−30CleanupHole Fill (μM2)150,00Hole Fill (μM2)0,00Adjust Size (pixels)−2Adjust Size (pixels)0Filters (only applied)Area (μM2)min. 15,00Area (μM2)min. 50,00 Note: Analysis definition is created by each user individually. One analysis pipeline can be used for as many scans as the user wishes to. i.Once the window with experimental images is open, choose “Launch Analysis” on the left side. Once the window with experimental images is open, choose “Launch Analysis” on the left side. ii.Pop-up window appears with the question whether you want to continue without defining Spectral Unmixing - click “Yes”. Pop-up window appears with the question whether you want to continue without defining Spectral Unmixing - click “Yes”. iii.New or Use Existing Analysis Definition – choose “Create New Analysis definition” and “Next”. New or Use Existing Analysis Definition – choose “Create New Analysis definition” and “Next”. iv.Analysis Type – Select “Basic Analyzer” and “Next”. Analysis Type – Select “Basic Analyzer” and “Next”. v.Image Channels – Select “Green” and “Red” – and “Next”. Image Channels – Select “Green” and “Red” – and “Next”. vi.Image Set Selection – select images that will be preview to define the analysis. Choose images from negative and positive control set and “Next”. Image Set Selection – select images that will be preview to define the analysis. Choose images from negative and positive control set and “Next”. vii.Analysis Definition – setting needs to be chosen individually. For point of reference Analysis definition used in this protocol is shown in Table 1. Once the set-up is done click on “Next”. Analysis Definition – setting needs to be chosen individually. For point of reference Analysis definition used in this protocol is shown in Table 1. Once the set-up is done click on “Next”. viii.Scan Times and Wells – select time points (0 and 5 h) and wells that will be analyzed (rows B-O, columns 3–22) and “Next”. Scan Times and Wells – select time points (0 and 5 h) and wells that will be analyzed (rows B-O, columns 3–22) and “Next”. ix.Save and Apply Analysis Definition – name your analysis and “Next”. Save and Apply Analysis Definition – name your analysis and “Next”. x.Summary – check details of your analysis and click “Finish”. Summary – check details of your analysis and click “Finish”. Workflow in the IncuCyte S3 Example of an analysis set-up. Table 1Details of analysis definition used in the siRNA screeningAnalysis definitionGreenRedSegmentation (Top-Hat)Radius (μM)100,00Radius (μM)100,00Threshold (GCU)15,00Threshold (GCU)0,400Edge Split On (Edge Sensitivity)−20Edge Split On (Edge Sensitivity)−30CleanupHole Fill (μM2)150,00Hole Fill (μM2)0,00Adjust Size (pixels)−2Adjust Size (pixels)0Filters (only applied)Area (μM2)min. 15,00Area (μM2)min. 50,00 Details of analysis definition used in the siRNA screening 39.Collect your data from IncuCyte S3 Software (Figure 4).a.Open Analysis Definition panel for your images.b.Choose Graph Metrics on the left side.c.Choose “Green Count (Per Image)”, select scans and wells for which you export data and click on “Export Data”.Note: Green Count represents SYTO™ 9 Green positive cells.d.Select the destination of the file, name exported file.e.Click on “Export”.f.Repeat steps 37.b-e for PI-positive cells (“Red Count (Per Image)”).Note: Exported data are in.txt files. To calculate ratio of PI-positive cells to SYTO 9 positive we recommend to use Microsoft-Excel spreadsheets or R.Note: Instructions presented on Figures 2, 3, and 4 are screenshots of analysis software version v2019B.Note: Verify implemented analysis manually to ensure that only true cell death events are counted.Figure 4Workflow in the IncuCyte S3Export of the experimental data. Collect your data from IncuCyte S3 Software (Figure 4).a.Open Analysis Definition panel for your images.b.Choose Graph Metrics on the left side.c.Choose “Green Count (Per Image)”, select scans and wells for which you export data and click on “Export Data”.Note: Green Count represents SYTO™ 9 Green positive cells.d.Select the destination of the file, name exported file.e.Click on “Export”.f.Repeat steps 37.b-e for PI-positive cells (“Red Count (Per Image)”).Note: Exported data are in.txt files. To calculate ratio of PI-positive cells to SYTO 9 positive we recommend to use Microsoft-Excel spreadsheets or R.Note: Instructions presented on Figures 2, 3, and 4 are screenshots of analysis software version v2019B.Note: Verify implemented analysis manually to ensure that only true cell death events are counted.Figure 4Workflow in the IncuCyte S3Export of the experimental data. a.Open Analysis Definition panel for your images. Open Analysis Definition panel for your images. b.Choose Graph Metrics on the left side. Choose Graph Metrics on the left side. c.Choose “Green Count (Per Image)”, select scans and wells for which you export data and click on “Export Data”.Note: Green Count represents SYTO™ 9 Green positive cells. Choose “Green Count (Per Image)”, select scans and wells for which you export data and click on “Export Data”.Note: Green Count represents SYTO™ 9 Green positive cells. Note: Green Count represents SYTO™ 9 Green positive cells. d.Select the destination of the file, name exported file. Select the destination of the file, name exported file. e.Click on “Export”. Click on “Export”. f.Repeat steps 37.b-e for PI-positive cells (“Red Count (Per Image)”).Note: Exported data are in.txt files. To calculate ratio of PI-positive cells to SYTO 9 positive we recommend to use Microsoft-Excel spreadsheets or R.Note: Instructions presented on Figures 2, 3, and 4 are screenshots of analysis software version v2019B.Note: Verify implemented analysis manually to ensure that only true cell death events are counted. Repeat steps 37.b-e for PI-positive cells (“Red Count (Per Image)”).Note: Exported data are in.txt files. To calculate ratio of PI-positive cells to SYTO 9 positive we recommend to use Microsoft-Excel spreadsheets or R.Note: Instructions presented on Figures 2, 3, and 4 are screenshots of analysis software version v2019B.Note: Verify implemented analysis manually to ensure that only true cell death events are counted. Note: Exported data are in.txt files. To calculate ratio of PI-positive cells to SYTO 9 positive we recommend to use Microsoft-Excel spreadsheets or R. Note: Instructions presented on Figures 2, 3, and 4 are screenshots of analysis software version v2019B. Note: Verify implemented analysis manually to ensure that only true cell death events are counted. Workflow in the IncuCyte S3 Export of the experimental data. Expected outcomes The protocol enables systematic identification of genes regulating pyroptosis through high-throughput siRNA screening coupled with live-cell imaging, avoiding fixation-related artifacts inherent to endpoint assays. SiCTRL and siCASP4 were used in this screening as negative and positive controls, respectively. Challenge of IFN-γ primed HeLa cells with transfected bacterial LPS triggers formation of noncanonical inflammasome, the activation of which leads to cell death. However, when genes involved in the pathway are silenced (e.g., CASP4) the cell death is blocked. Application of fluorescent dyes makes it possible to distinguish dead cells (PI-positive) from the entire population (SYTO 9 Green positive) and their quantification (Figures 5A and 5B). To analyze screening data, calculate and log-transform mean values of cell death from three replicates. Then normalize these values to the control (siCTRL + IFN-γ) using the median. Next calculate robust z-scores based on the median, and present the data on a logarithmic scale. Genes whose silencing reduces the PI-to-SYTO 9 ratio compared to negative controls shows decreased values of robust z-scores and are identified as candidate pyroptosis regulators. To further confirm the accuracy of the protocol siRNA library also targeted genes, whose role in the pyroptosis was already established, such as CASP4 or GSDMD. For them, as for some other tested genes we observed significantly reduced cell death levels upon their silencing compared to the control population (Figure 5C).Figure 5LPS transfection leads to pyroptosis in HeLa epithelial cells stimulated with IFN-γ(A–C) Microscopic cell death analysis of (A and B) added screening controls from Columns 4 and 21 of assay plates and (C) test samples.(A) Representative immunofluorescent results from the screening experiment.(B) Quantification of PI-positive cells in control populations.(C) Quantification of PI-positive cells in test samples and control populations presented in B. Cells were transfected with LPS, stained with SYTO™ 9 Green and propidium iodide (PI) (A, B and C). DNA of only dead cells is stained by PI, whereas DNA of both dead and live cells is stained with SYTO™9 Green. Cells were treated with siRNA and IFN-γ as indicated (A–C). Percentage of dead cells is calculated as ratio of PI-positive nuclei to all nuclei (B and C). Data are shown as mean ± SEM (B and C), statistical significance was assessed by one-way ANOVA with Dunnett’s multiple comparisons (B and C, siCTRL vs other samples); ∗∗∗∗p < 0,0001. Z′ factor = 0.23 (B). Scale bar, 400 μm. LPS transfection leads to pyroptosis in HeLa epithelial cells stimulated with IFN-γ (A–C) Microscopic cell death analysis of (A and B) added screening controls from Columns 4 and 21 of assay plates and (C) test samples. (A) Representative immunofluorescent results from the screening experiment. (B) Quantification of PI-positive cells in control populations. (C) Quantification of PI-positive cells in test samples and control populations presented in B. Cells were transfected with LPS, stained with SYTO™ 9 Green and propidium iodide (PI) (A, B and C). DNA of only dead cells is stained by PI, whereas DNA of both dead and live cells is stained with SYTO™9 Green. Cells were treated with siRNA and IFN-γ as indicated (A–C). Percentage of dead cells is calculated as ratio of PI-positive nuclei to all nuclei (B and C). Data are shown as mean ± SEM (B and C), statistical significance was assessed by one-way ANOVA with Dunnett’s multiple comparisons (B and C, siCTRL vs other samples); ∗∗∗∗p < 0,0001. Z′ factor = 0.23 (B). Scale bar, 400 μm. Limitations In this protocol Thermo Fisher Silencer Select siRNA custom-made library was used. According to producer information, knock-down on mRNA level is achieved 24–48 h post transfection. However, this may not affect the corresponding protein level. Likely, reduction of the levels of some proteins may require longer culturing time, while this protocol shortens the entire experiment to 48 h. It was experimentally established that in the case of CASP4 it is an adequate time for the protein to be efficiently downregulated (Figure 6). For each screening experiment, one needs to determine the time sufficient to observe expected phenotype or its reversion with a positive/negative control for the assay. It is possible that very stable proteins may still be present in the cell proteome upon applied culturing time and hence silencing of this particular target may not be efficient enough to result in the expected phenotype, leading to false negative results in the screen.Figure 6Time course of caspase-4 silencingCells were treated with siRNA as indicated and after different time periods cells were primed with IFN-γ. After additional 12 h proteins were extracted. Time periods are shown as total silencing time (from siRNA treatment to proteins extractions). Blots were probed with the indicated antibodies; β-actin, loading control. Time course of caspase-4 silencing Cells were treated with siRNA as indicated and after different time periods cells were primed with IFN-γ. After additional 12 h proteins were extracted. Time periods are shown as total silencing time (from siRNA treatment to proteins extractions). Blots were probed with the indicated antibodies; β-actin, loading control. Also, it is advised to evaluate the assay used for hit identification to assess its robustness. One method for this evaluation is to calculate the Z′ factor, which integrates the dynamic range of the measured signal between positive and negative controls and data variability into a single value.21,22 Assessing the Z′ factor is beneficial not only during the development phase of the assay but also while conducting the screening process, as it helps monitor data quality across different plates. A suboptimal Z′ factor, particularly in complex cell-based assays, does not necessarily invalidate the screening process23,24 but highlights the potential for misidentifying hits. This consideration should be factored in when planning the validation of obtained results. A less robust assay increases the likelihood of misidentifying candidate hits, and may require validating a larger number of candidates. Troubleshooting Problem 1 Inefficient downregulation of studied proteins (related to major step high-throughput reverse siRNA transfection of HeLa cells). Potential solution Try to increase the experiment duration but be aware that it should last less than 60 h overall due to cell death occurring at later time points (applies to step 23). Problem 2 Observed knock-down is not complete (related to major step high-throughput reverse siRNA transfection of HeLa cells). Potential solution Increase the concentration of siRNAs or design new siRNA (applies to point 5–7 of before you begin section and/or step 2 and 4). Do not exceed the final concentration of 20 nM (in case of Silencer Select siRNA). Problem 3 Cells do not reach the confluency of 90–95% whilst they are transfected with LPS (related to major step: LPS transfection, fluorescent staining, and data visualization). Potential solutions Increase the concentration of cells in siRNA-transfected wells (applies to step 19 and 20). Depending on the cell line, cells concentration in the screening needs to be adjusted prior to final experiment. Problem 4 LPS transfection is not efficient (related to major step LPS transfection, fluorescent staining, and data visualization). Potential solution Increase the LPS concentration in the screening or try to change transfection reagent (e.g., to RNAiMAX) (applies to step 32). Problem 5 Available live-imaging machine has only one fluorescent channel (related to major step LPS transfection, fluorescent staining, and data visualization). Potential solution If the machine used for imaging allows for Differential Interference Contrast (DIC) microscopy, only dye for visualization of dead cells can be used. In such cases, results would be obtained by calculating a ratio of dead cells to confluency (applies to step 38 and 39). Problem 6 Multidrop is not available (related to step 10, 12, 19, 20, 28, 36 and 37). Potential solution Multi-channel pipette can be used alternatively. Resource availability Lead contact Further inquiries and resource requests can be addressed to the lead contact, Michal P. Wandel (mwandel@ibb.waw.pl). Technical contact Technical questions on executing this protocol should be directed to and will be answered by the technical contact, Aleksandra Bajger (abajger@ibb.waw.pl). Materials availability This study did not generate new unique reagents or materials. Data and code availability Raw data can be obtained from the lead contact upon reasonable request and prior data publication. No code was used for the analysis in this study. Acknowledgments We thank Damian Graczyk (IBB PAS and Adamed Pharma S.A.) for guidance on the IncuCyte® S3 operating procedures. This work was supported by the 10.13039/501100014434Polish National Agency for Academic Exchange (PPN/PPO/2020/1/00020/U/00001 to M.P.W.), National Science Center (2020/37/B/NZ6/03338 to M.P.W.), and by the EMBO Installation Grant (IG-4739 to M.P.W.). The Figures were created in part using BioRender (Biorender.com). Author contributions M.P.W. acquired funding and designed the work. A.B. performed the experiments, analyzed the data, and wrote the manuscript draft. L.S.B. analyzed the data. L.S.B. and R.J.S. provided technical expertise. M.P.W. and R.J.S. reviewed and edited the manuscript. All the authors have read and approved the manuscript. Declaration of interests The authors declare no competing interests.